← Open Payments lookup

CRAIGIN SHIMMENS: Open Payments

NPI 1871215897 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,556 in 115 payments from 38 companies in 2025. Trend: 2023 $2,472 · 2024 $2,530 · 2025 $2,556

Food & beverage: $2,556
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation17$352
AstraZeneca Pharmaceuticals LP11$253
Janssen Biotech, Inc.10$219
Merck Sharp & Dohme LLC11$188
PFIZER INC.9$148
Novocure Inc.1$143
ABBVIE INC.5$105
Myriad Genetic Laboratories, Inc.1$105
Daiichi Sankyo Inc.4$96
Takeda Pharmaceuticals U.S.A., Inc.3$86

Products named: KEYTRUDA, PLUVICTO, Optune Lua (NovoTTF-200T), MYRISK, ENHERTU, DARZALEX, Zoladex, Lenvima.

Industry payments across MO — which companies pay providers there.